Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: ATRIAL FIBRILLATION - COMPLICATIONS , . Treffer: 17

2022

Bernegger, A; Mikšová, D; Posekany, A; Krebs, S; Ferrari, J; Greisenegger, S; Gattringer, T; Lang, W; Kiechl, S; Sykora, M, , Austrian, Stroke, Unit, Registry, Collaborators Time trends in stroke severity in the years 2005 to 2020: results from the Austrian Stroke Unit Registry.
J Neurol. 2022; 269(8): 4396-4403. Doi: 10.1007/s00415-022-11079-x
Web of Science PubMed FullText FullText_MUG

 

2019

Lopes, RD; Heizer, G; Aronson, R; Vora, AN; Massaro, T; Mehran, R; Goodman, SG; Windecker, S; Darius, H; Li, J; Averkov, O; Bahit, MC; Berwanger, O; Budaj, A; Hijazi, Z; Parkhomenko, A; Sinnaeve, P; Storey, RF; Thiele, H; Vinereanu, D; Granger, CB; Alexander, JH; AUGUSTUS Investigators Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
N Engl J Med. 2019; 380(16): 1509-1524. Doi: 10.1056/NEJMoa1817083 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Lang, C; Seyfang, L; Ferrari, J; Gattringer, T; Greisenegger, S; Willeit, K; Toell, T; Krebs, S; Brainin, M; Kiechl, S; Willeit, J; Lang, W; Knoflach, M; Austrian Stroke Registry Collaborators Do Women With Atrial Fibrillation Experience More Severe Strokes? Results From the Austrian Stroke Unit Registry.
Stroke. 2017; 48(3):778-780 Doi: 10.1161/STROKEAHA.116.015900 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Maikranz, V; Siebenhofer, A; Ulrich, LR; Mergenthal, K; Schulz-Rothe, S; Kemperdick, B; Rauck, S; Pregartner, G; Berghold, A; Gerlach, FM; Petersen, JJ Does a complex intervention increase patient knowledge about oral anticoagulation? - a cluster-randomised controlled trial.
BMC Fam Pract. 2017; 18(1):15-15 Doi: 10.1186/s12875-017-0588-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zirlik, A; Bode, C Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation.
J THROMB THROMBOLYS. 2017; 43(3): 365-379. Doi: 10.1007/s11239-016-1446-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zweiker, D; Zweiker, R; Winkler, E; Roesch, K; Schumacher, M; Stepan, V; Krippl, P; Bauer, N; Heine, M; Reicht, G; Zweiker, G; Sprenger, M; Watzinger, N Association between subjective risk perception and objective risk estimation in patients with atrial fibrillation: a cross-sectional study.
BMJ Open. 2017; 7(9):e018242-e018242 Doi: 10.1136/bmjopen-2017-018242 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Silbernagel, G; Spirk, D; Hager, A; Baumgartner, I; Kucher, N Electronic Alert System for Improving Stroke Prevention Among Hospitalized Oral-Anticoagulation-Naïve Patients With Atrial Fibrillation: A Randomized Trial.
J Am Heart Assoc. 2016; 5(7): Doi: 10.1161/JAHA.116.003776 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Stachon, P; Ahrens, I; Faber, T; Bode, C; Zirlik, A Asymptomatic atrial fibrillation and risk of stroke.
PANMINERVA MED. 2015; 57(4): 211-215.
Web of Science PubMed

 

2014

Ulrich, LR; Mergenthal, K; Petersen, JJ; Roehl, I; Rauck, S; Kemperdick, B; Schulz-Rothe, S; Berghold, A; Siebenhofer, A Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial.
BMC Fam Pract. 2014; 15(10):170-170 Doi: 10.1186/s12875-014-0170-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Jadidi, AS; Cochet, H; Shah, AJ; Kim, SJ; Duncan, E; Miyazaki, S; Sermesant, M; Lehrmann, H; Lederlin, M; Linton, N; Forclaz, A; Nault, I; Rivard, L; Wright, M; Liu, X; Scherr, D; Wilton, SB; Roten, L; Pascale, P; Derval, N; Sacher, F; Knecht, S; Keyl, C; Hocini, M; Montaudon, M; Laurent, F; Haïssaguerre, M; Jaïs, P Inverse relationship between fractionated electrograms and atrial fibrosis in persistent atrial fibrillation: combined magnetic resonance imaging and high-density mapping.
J Am Coll Cardiol. 2013; 62(9):802-812 Doi: 10.1016/j.jacc.2013.03.081 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Connolly, SJ; Eikelboom, J; Joyner, C; Diener, HC; Hart, R; Golitsyn, S; Flaker, G; Avezum, A; Hohnloser, SH; Diaz, R; Talajic, M; Zhu, J; Pais, P; Budaj, A; Parkhomenko, A; Jansky, P; Commerford, P; Tan, RS; Sim, KH; Lewis, BS; Van Mieghem, W; Lip, GY; Kim, JH; Lanas-Zanetti, F; Gonzalez-Hermosillo, A; Dans, AL; Munawar, M; O'Donnell, M; Lawrence, J; Lewis, G; Afzal, R; Yusuf, S; AVERROES Steering Committee and Investigators Apixaban in patients with atrial fibrillation.
N Engl J Med. 2011; 364(9):806-817 Doi: 10.1056/NEJMoa1007432 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Miyazaki, S; Shah, AJ; Scherr, D; Haïssaguerre, M Atrial fibrillation: pathophysiology and current therapy.
Ann Med. 2011; 43(6):425-436 Doi: 10.3109/07853890.2011.554426
Web of Science PubMed FullText FullText_MUG

 

Patel, MR; Mahaffey, KW; Garg, J; Pan, G; Singer, DE; Hacke, W; Breithardt, G; Halperin, JL; Hankey, GJ; Piccini, JP; Becker, RC; Nessel, CC; Paolini, JF; Berkowitz, SD; Fox, KA; Califf, RM; ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
N Engl J Med. 2011; 365(10):883-891 Doi: 10.1056/NEJMoa1009638 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Lemmens, R; Buysschaert, I; Geelen, V; Fernandez, I; Montaner, J; Schmidt, H; Schmidt, R; Attia, J; Maguire, J; Levi, C; Jood, K; Blomstrand, C; Jern, C; Wnuk, M; Slowik, A; Lambrechts, D; Thijs, V; International Stroke Genetics Consortium The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology.
Stroke. 2010; 41(9): 1850-1857. Doi: 10.1161/STROKEAHA.110.587980 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Lip, GY; Rasmussen, LH; Olsson, SB; Jensen, EC; Persson, AL; Eriksson, U; Wåhlander, KF; Steering Committee Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.
Eur Heart J. 2009; 30(23):2897-2907 Doi: 10.1093/eurheartj/ehp318 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Scherr, D; Dalal, D; Chilukuri, K; Dong, J; Spragg, D; Henrikson, CA; Nazarian, S; Cheng, A; Berger, RD; Abraham, TP; Calkins, H; Marine, JE Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation.
J Cardiovasc Electrophysiol. 2009; 20(4):379-384 Doi: 10.1111/j.1540-8167.2008.01336.x
Web of Science PubMed FullText FullText_MUG

 

2006

Deplanque, D; Leys, D; Parnetti, L; Schmidt, R; Ferro, J; de Reuck, J; Mas, JL; Gallai, V; SAFE II Investigators Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge.
Cerebrovasc Dis. 2006; 21(5-6):372-379 Doi: 10.1159/000091546
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum